AI-Assisted 2D Fetal Brain Ultrasound for Intracranial Anomaly Detection

NCT ID: NCT07261618

Last Updated: 2025-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

800 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-15

Study Completion Date

2025-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Timely detection of fetal brain anomalies is critical for improving prenatal counseling and postnatal neurological outcomes. Ultrasonography is the most commonly used and effective imaging method for evaluating fetal structures; however, diagnostic accuracy can be affected by operator experience, fetal position, and image quality, leading to variability in interpretation. Artificial intelligence (AI)-based image analysis offers a new opportunity to standardize diagnostic assessment and reduce subjectivity in ultrasound interpretation.

This study aims to evaluate the diagnostic accuracy and clinical applicability of an AI-assisted model (Alyssia) designed to analyze archived 2D fetal brain ultrasound images. The model will be trained and validated to distinguish between normal and abnormal intracranial findings, focusing particularly on the lateral ventricles and other relevant brain regions. The research employs an observational, retrospective design using anonymized ultrasound data obtained during routine prenatal examinations between 18 and 24 weeks of gestation.

Expert clinicians will review and label all eligible images to establish ground truth classifications for model training and validation. A deep learning-based algorithm will be developed to automatically classify these images, and its performance will be evaluated using accuracy, sensitivity, specificity, precision, and F1-score metrics. Misclassified cases will be qualitatively analyzed to determine contributing factors such as image quality, anatomical variability, and gestational differences.

By comparing AI model outputs with expert-labeled references, the study will assess the model's ability to enhance diagnostic standardization and reduce inter-observer variability. The findings are expected to provide valuable insights into the integration of AI-based decision support systems in prenatal neurosonography. Ultimately, this research aims to support earlier and more reliable detection of fetal brain anomalies, contributing to improved prenatal care and healthier outcomes for mothers and infants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracranial Anomalies Ultrasound Imaging Artificial Intelligence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal Fetal Brain Images

Archived 2D fetal brain ultrasound images classified as normal by expert reviewers.

Alyssia - AI-Assisted Diagnostic Model for Fetal Brain Ultrasound

Intervention Type DIAGNOSTIC_TEST

Artificial intelligence-based diagnostic tool designed to classify archived 2D fetal brain ultrasound images as normal or abnormal to detect intracranial anomalies.

Abnormal Fetal Brain Images

Archived 2D fetal brain ultrasound images with confirmed intracranial anomalies, labeled by experts.

Alyssia - AI-Assisted Diagnostic Model for Fetal Brain Ultrasound

Intervention Type DIAGNOSTIC_TEST

Artificial intelligence-based diagnostic tool designed to classify archived 2D fetal brain ultrasound images as normal or abnormal to detect intracranial anomalies.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Alyssia - AI-Assisted Diagnostic Model for Fetal Brain Ultrasound

Artificial intelligence-based diagnostic tool designed to classify archived 2D fetal brain ultrasound images as normal or abnormal to detect intracranial anomalies.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Archived 2D fetal brain ultrasound images obtained during routine prenatal examinations.
* Gestational age between 18 and 24 weeks at the time of imaging.
* Maternal age between 18 and 45 years.
* Clear visualization of the lateral ventricles and other intracranial regions.
* Images meeting diagnostic quality standards suitable for analysis.
* Fully anonymized images with no patient identifiers.
* Availability of expert assessment to classify each image as normal or abnormal.

Exclusion Criteria

* Ultrasound images with poor diagnostic quality or motion artifacts.
* Incomplete, duplicate, or corrupted image records.
* Ambiguous gestational age or missing clinical metadata.
* Images containing any identifiable patient information.
* Cases outside the specified gestational window (before 18 or after 24 weeks).
* Images unrelated to the fetal brain (misfiled or mislabeled data).
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sanliurfa Mehmet Akif Inan Education and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nefise Nazlı YENIGUL

Associate Professor, Obstetrics and Gynecology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nefise nazlı Yenigül

Bursa, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MEF University Ethics Committe

Identifier Type: OTHER

Identifier Source: secondary_id

E-47749665-050.04-4465

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.